Insider Stock Trading History of Deerfield International Master Fund, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Deerfield International Master Fund, L.p. since year 2005. The trader's CIK number is 1565089. At the time of this reporting, Deerfield International Master Fund, L.p. is the of Proteon Therapeutics Inc . (stock ticker symbol PRTO). See this page for all insider trading activities at Proteon Therapeutics Inc .

Note that in the past Deerfield International Master Fund, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Deerfield International Master Fund, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-30 PRTO Proteon Therapeutics Inc Buy 110,557 1.75 193,474
2017-11-30 PRTO Proteon Therapeutics Inc Sale 110,557 1.75 193,474
2017-04-26 EHTH Ehealth, Inc. Sale 113,245 11.52 1,304,582
2017-04-27 EHTH Ehealth, Inc. Sale 313,709 11.71 3,673,532
2017-04-13 EHTH Ehealth, Inc. Sale 150,000 11.00 1,650,000
2017-04-11 EHTH Ehealth, Inc. Sale 33,440 11.01 368,241
2017-04-10 EHTH Ehealth, Inc. Sale 79,757 11.04 880,357
2017-04-07 EHTH Ehealth, Inc. Sale 118,904 11.72 1,393,079
2016-06-20 EHTH Ehealth, Inc. Sale 178,454 14.20 2,533,511
2016-06-21 EHTH Ehealth, Inc. Sale 26,400 14.30 377,546
2016-06-14 EHTH Ehealth, Inc. Sale 43,300 13.88 601,177
2016-06-08 EHTH Ehealth, Inc. Sale 28,080 13.84 388,627
2016-06-07 EHTH Ehealth, Inc. Sale 7,154 13.89 99,383
2016-06-06 EHTH Ehealth, Inc. Sale 28,502 14.00 399,028
2016-06-01 EHTH Ehealth, Inc. Sale 5 13.80 69
2016-06-02 EHTH Ehealth, Inc. Sale 42,668 13.87 591,762
2016-05-31 EHTH Ehealth, Inc. Sale 56,835 13.84 786,653
2016-05-26 EHTH Ehealth, Inc. Sale 93,965 14.16 1,330,826
2016-05-27 EHTH Ehealth, Inc. Sale 72,649 14.00 1,016,940
2016-05-25 EHTH Ehealth, Inc. Sale 45,967 14.25 655,167
2016-02-09 ZFGN Zafgen, Inc. Buy 113,923 5.73 652,664
2016-02-10 ZFGN Zafgen, Inc. Buy 151,226 6.23 942,440
2016-02-11 ZFGN Zafgen, Inc. Buy 2,344 6.19 14,504
2015-07-17 ATRS Antares Pharma Inc Sale 125,769 2.20 277,069
2015-07-20 ATRS Antares Pharma Inc Sale 106,024 2.13 225,407
2015-07-06 ATRS Antares Pharma Inc Sale 191,513 2.12 406,007
2015-07-07 ATRS Antares Pharma Inc Sale 198,651 2.09 414,783
2015-07-08 ATRS Antares Pharma Inc Sale 444,341 2.05 912,232
2015-06-30 ATRS Antares Pharma Inc Sale 608,691 2.08 1,266,685
2015-06-29 ATRS Antares Pharma Inc Sale 60,695 2.18 132,072
2015-07-01 ATRS Antares Pharma Inc Sale 43,836 2.11 92,318
2015-06-25 ATRS Antares Pharma Inc Sale 175,200 2.25 394,200
2015-06-26 ATRS Antares Pharma Inc Sale 318,534 2.24 714,790
2015-06-24 ATRS Antares Pharma Inc Sale 263,118 2.31 607,539
2015-06-19 ATRS Antares Pharma Inc Sale 141,550 2.41 340,569
2015-06-22 ATRS Antares Pharma Inc Sale 176,483 2.41 424,618
2015-06-23 ATRS Antares Pharma Inc Sale 181,862 2.35 427,193
2015-06-18 ATRS Antares Pharma Inc Sale 210,701 2.48 522,117
2015-06-17 ATRS Antares Pharma Inc Sale 53,605 2.40 128,920
2015-06-16 ATRS Antares Pharma Inc Sale 214,060 2.40 514,386
2015-06-15 ATRS Antares Pharma Inc Sale 190,141 2.40 456,718
2015-06-11 ATRS Antares Pharma Inc Sale 339,272 2.47 839,019
2015-06-12 ATRS Antares Pharma Inc Sale 218,617 2.43 530,364
2015-03-06 EHTH Ehealth, Inc. Sale 1,342,573 9.52 12,781,294
2014-08-07 EHTH Ehealth, Inc. Buy 3,131 21.05 65,907
2014-08-06 LOXO Loxo Oncology, Inc. Buy 1,089,656 13.02 14,184,052
2014-08-04 EHTH Ehealth, Inc. Buy 155,470 20.57 3,198,795
2014-08-05 EHTH Ehealth, Inc. Buy 3,770 20.99 79,132
2014-08-01 EHTH Ehealth, Inc. Buy 170,300 19.22 3,273,166
2014-08-05 AAVL Avalanche Biotechnologies, Inc. Buy 1,334,467 23.83 31,803,017

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deerfield International Master Fund, L.p. ( of Proteon Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.